Stuttgart
01.10.26 | 21:55
0,079 Euro
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| IXICO Aktie jetzt für 0€ handeln | |||||
| Do | IXICO plc - IXICO present PD research at radiology conference | - | RNS | ||
| 27.07. | IXICO plc - Share option award | 6 | RNS | ||
| 15.07. | IXICO plc - Director/PDMR Shareholding | 6 | RNS | ||
| 13.07. | IN BRIEF: Ixico notes ending of Huntington's disease programmes | 8 | Alliance News | ||
| 13.07. | WINNERS & LOSERS: Ixico lower order book; Pennant sees revenue jump | 7 | Alliance News | ||
| 13.07. | IXICO plc - HD Industry Update | 6 | RNS | ||
| 07.07. | TRADING UPDATES: Ixico ups guidance; Steppe Cement revenue up | 7 | Alliance News | ||
| 07.07. | WINNERS & LOSERS: Beauty Tech ups guidance; Ixico to beat expectations | 9 | Alliance News | ||
| 07.07. | Ixico flags full-year revenue ahead of market expectations | 7 | Sharecast | ||
| 07.07. | IXICO plc - Trading Update | 6 | RNS | ||
| 19.06. | IXICO plc - Exercise of Options | 7 | RNS | ||
| 08.06. | IXICO plc - Scientific advisors & partners update | 9 | RNS | ||
| 22.05. | IXICO plc - Company presentation at Mello 2026 | 10 | RNS | ||
| 21.05. | IXICO plc - Contract win and contract extension | 10 | RNS | ||
| 19.05. | AIM Market Roundup: Novacyt, Ixico, Pennant | 12 | The Armchair Trader | ||
| 19.05. | IN BRIEF: Ixico reaffirms growth guidance as half-year revenue rises | 11 | Alliance News | ||
| 19.05. | Ixico reports higher interim revenue, larger order book | 11 | Sharecast | ||
| 19.05. | IXICO plc - Interim results for six months ending 31/03/2026 | 10 | RNS | ||
| 12.05. | IXICO plc - IXICO Updates AI Neuroimaging Platform | 13 | RNS | ||
| 27.04. | IXICO plc - Holding(s) in Company | 18 | RNS |
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 33,370 | -1,81 % | Eli Lilly und Novo Nordisk bekommen neue Konkurrenz - warum der 100-Milliarden-Dollar-Markt immer mehr Biotech-Unternehmen anzieht | ||
| AURORA CANNABIS | 3,452 | -0,92 % | Aurora Cannabis: Beschwerde bringt den Deal ins Wanken | ||
| CANOPY GROWTH | 0,772 | -2,01 % | Canopy Growth Corporation: Canopy Growth Appoints Sebastian Blöte as Country Manager for Germany | Mr. Blöte's appointment strengthens Canopy Growth's commercial leadership as it drives growth across its European medical cannabis businessCanopy Growth Corporation ("Canopy Growth", "our", "we" or... ► Artikel lesen | |
| TILRAY BRANDS | 3,135 | -1,10 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 451,80 | +0,22 % | $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | ||
| MPH HEALTH CARE | 26,700 | -1,11 % | MPH Health Care: 5-Euro-Dividende - das wird übersehen | ||
| CRONOS GROUP | 2,840 | -0,77 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 0,931 | -0,53 % | Original-Research: SYNBIOTIC SE (von NuWays AG): Under review | Original-Research: SYNBIOTIC SE - from NuWays AG
24.08.2026 / 09:00 CET/CEST
Dissemination of a Research, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for... ► Artikel lesen | |
| DIGICANN VENTURES | 0,010 | -24,00 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| EYEPOINT | 2,900 | +0,69 % | XFRA PV3B: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,910 | +4,12 % | ORGANIGRAM GLOBAL INC. - 6-K, Report of foreign issuer | ||
| GREEN THUMB INDUSTRIES | 5,940 | -1,49 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,107 | 0,00 % | Immortal Dragons: Sundial Initiative Advisor Boyang Wang Sponsors Nakauchi Lab's Work on "Bodyoids" | SINGAPORE, SG / ACCESS Newswire / July 30, 2026 / Boyang Wang, advisor to the Sundial Initiative and founder and CEO of the longevity fund Immortal Dragons, has sponsored the Nakauchi Lab, led by stem... ► Artikel lesen | |
| SINOPHARM | 1,682 | 0,00 % | Harbour BioMed and Sinopharm Enter Strategic Collaboration to Establish Innovation R&D Consortium | CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, July 27, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,035 | -37,27 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen |
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IXICO PLC finden Sie auf Wallstreet Online.